The pharmaceutical trade is bracing for probably the most important growth of presidency regulation of drug costs in a long time regardless of success in watering down proposals from congressional Democrats that may have gone a lot additional.
The Home final week authorized a roughly $2 trillion social-spending and local weather invoice supported by President Biden that requires the federal government to barter costs for some older high-cost medicines lined by Medicare. The invoice additionally caps annual drug value will increase on the price of inflation. The measures cut back federal drug spending—and trade income—by $128 billion over 10 years, in keeping with the Congressional Finances Workplace.
